Valuation: DocMorris AG

Market Cap 523M 640M 561M 481M 901M 61.1B 917M 6.2B 2.43B 30.3B 2.4B 2.35B 105B P/E 2026 *
-6.82x
P/E 2027 * -13.7x
Enterprise Value 723M 884M 776M 665M 1.25B 84.49B 1.27B 8.57B 3.36B 41.9B 3.32B 3.25B 145B EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.55x
Free-Float
66.45%
Yield 2026 *
-
Yield 2027 * -
1 year 7.45
Extreme 7.454
10.24
3 years 7.45
Extreme 7.454
108.05
5 years 7.45
Extreme 7.454
425
10 years 7.45
Extreme 7.454
547
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-27.18%-.--% - - 640M
+5.37%+6.16%-19.92%-28.95% 15.44B
+4.66%+5.59%-25.98%-34.96% 7.07B
+3.96%+9.19%-12.57%-2.87% 6.22B
+1.49%+3.74%-6.06%-29.96% 4.02B
+1.01%+4.00%-27.13%-46.05% 3.26B
+1.24%-0.37%+9.73%-32.86% 3.17B
+0.87%-4.84%-41.22%-23.50% 3.04B
-0.26%+4.07%-12.44%+3.00% 2.66B
+0.96%+2.32%+101.83% - 2.65B
Average -0.79%+1.39%-3.75%-24.52% 5.28B
Weighted average by Cap. +2.92%+0.46%-11.35%-25.63%

Financials

2026 *2027 *
Net sales 1.24B 1.51B 1.33B 1.14B 2.13B 145B 2.17B 14.67B 5.74B 71.7B 5.68B 5.56B 248B 1.39B 1.7B 1.49B 1.28B 2.39B 162B 2.44B 16.48B 6.45B 80.52B 6.38B 6.24B 278B
Net income -81.01M -99.12M -86.99M -74.51M -140M -9.47B -142M -961M -376M -4.7B -372M -364M -16.23B -43.68M -53.44M -46.9M -40.17M -75.3M -5.11B -76.6M -518M -203M -2.53B -201M -196M -8.75B
Net Debt 200M 245M 215M 184M 345M 23.39B 351M 2.37B 929M 11.6B 919M 899M 40.08B 236M 289M 253M 217M 407M 27.58B 414M 2.8B 1.1B 13.68B 1.08B 1.06B 47.26B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
1,337
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.69CHF
Average target price
10.22CHF
Spread / Average Target
-4.41%

Quarterly revenue - Rate of surprise